Skip to main content
Top
Published in: BMC Cancer 1/2016

Open Access 01-12-2016 | Research article

Factors influencing diagnosis delay of advanced breast cancer in Moroccan women

Authors: A. Maghous, F. Rais, S. Ahid, N. Benhmidou, K. Bellahamou, H. Loughlimi, E. Marnouche, S. Elmajjaoui, H. Elkacemi, T. Kebdani, N. Benjaafar

Published in: BMC Cancer | Issue 1/2016

Login to get access

Abstract

Background

Delay in the diagnosis of breast cancer in symptomatic women of 3 months or more is associated with advanced stage and low survival. We conducted this study to learn more about the extent and reasons behind diagnosis delay of advanced breast cancer in Moroccan women.

Methods

A group of patients with advanced breast cancer were interviewed at the National Institute of Oncology in Rabat during the period from February to December 2014. Diagnosis delay was devised into patient delay and system delay. Patient delay was defined as time from first symptoms until first medical consultation. System delay was defined as time from first presentation to a health care provider until definite diagnosis or treatment. Prospective information and clinical data were collected on a form during an interview with each patient and from medical records.

Results

In all, 137 patients were interviewed. The mean age of women was 48.3 ± 10.4 years. The median of consultation time was 6[4,12] months and the median of diagnosis time was 1[1,3] months. Diagnosis delay was associated to a personal reason in 96 (70.1 %) patients and to a medical reason in 19 (13.9 %) patients. A number of factors predicted diagnosis delay: symptoms were not considered serious in 66 (55.9 %) patients; traditional therapy was applied in 15 (12.7 %) patients and fear of cancer diagnosis and/or treatment in 14 (11.9 %) patients. A use of traditional methods was significantly associated with rural residence and far away from basic health center (p = 0.000). Paradoxically, a family history of breast cancer was significantly higher in who report a fear of cancer diagnosis and/or treatment to diagnosis delay (p < 0.001). Also, a significantly higher risk of more than 6 months delay was found among rural women (P = 0.035) and women who live far away from specialized care center (P = 0.001).

Conclusions

Diagnosis delay is very serious problem in Morocco. Diagnosis delay was associated with complex interactions between several factors and with advanced stages. There is a need for improving breast cancer information in our populations and training of general practitioners to reduce advanced breast cancer by promoting early detection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.CrossRefPubMed Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.CrossRefPubMed
2.
go back to reference Tazi MA, Er-Raki A, Benjaafar N. Cancer incidence in Rabat, Morocco: 2006–2008. Ecancer. 2013;7:338. Tazi MA, Er-Raki A, Benjaafar N. Cancer incidence in Rabat, Morocco: 2006–2008. Ecancer. 2013;7:338.
3.
go back to reference Parkin DM, Fernández LMG. Use of statistics to assess the global burden of breast cancer. Breast J. 2006;12(1):S70–80.CrossRefPubMed Parkin DM, Fernández LMG. Use of statistics to assess the global burden of breast cancer. Breast J. 2006;12(1):S70–80.CrossRefPubMed
4.
go back to reference Kothari A, Fentiman IS. Diagnostic delays in breast cancer and impact on survival. Int J Clin Pract. 2003;57(3):200–3.PubMed Kothari A, Fentiman IS. Diagnostic delays in breast cancer and impact on survival. Int J Clin Pract. 2003;57(3):200–3.PubMed
6.
go back to reference Plan national de Prévention et du contrôle du cancer, Association Lalla Salma de Lutte contre le Cancer (ALSC). Etude des stades de diagnostique et des résultats de traitement des cancers au Maroc, vol. 3. 2009. p. 123. Plan national de Prévention et du contrôle du cancer, Association Lalla Salma de Lutte contre le Cancer (ALSC). Etude des stades de diagnostique et des résultats de traitement des cancers au Maroc, vol. 3. 2009. p. 123.
7.
go back to reference Ozmen V, Boylu S, Ok E, Canturk NZ, Celik V, Kapkac M, Girgin S, Tireli M, Ihtiyar E, Demircan O, Baskan MS, Koyuncu A, Tasdelen I,Dumanli E, Ozdener F, Zaborek P. Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases Societies. Eur J Public Health. 2015;25(1):9–14.CrossRefPubMed Ozmen V, Boylu S, Ok E, Canturk NZ, Celik V, Kapkac M, Girgin S, Tireli M, Ihtiyar E, Demircan O, Baskan MS, Koyuncu A, Tasdelen I,Dumanli E, Ozdener F, Zaborek P. Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases Societies. Eur J Public Health. 2015;25(1):9–14.CrossRefPubMed
8.
go back to reference Fedewa SA, Edge SB, Stewart AK, et al. Race and ethnicity are associated with delays in breast cancer treatment (2003–2006). J Health Care Poor Underserved. 2011;22:128–41.PubMed Fedewa SA, Edge SB, Stewart AK, et al. Race and ethnicity are associated with delays in breast cancer treatment (2003–2006). J Health Care Poor Underserved. 2011;22:128–41.PubMed
10.
go back to reference Kathryn J. Ruddy MD, MPH, Shari Gelber MS, MSW, Rulla M. Tamimi ScD, Lidia Schapira MD, Steven E. Come MD, Meghan E. Meyer BS, Eric P. Winer MD and Ann H. Breast cancer presentation and diagnostic delays in young women. Cancer. 2014;120:20–5. Kathryn J. Ruddy MD, MPH, Shari Gelber MS, MSW, Rulla M. Tamimi ScD, Lidia Schapira MD, Steven E. Come MD, Meghan E. Meyer BS, Eric P. Winer MD and Ann H. Breast cancer presentation and diagnostic delays in young women. Cancer. 2014;120:20–5.
11.
go back to reference Landolsi A1, Gahbiche S, Chaafii R, Chabchoub I, Ben Fatma L, Hochlef M, Gharbi O, Ben Ahmed S. Reasons of diagnostic delay of breast cancer in Tunisian women (160 patients in the central region of Tunisia). Tunis Med. 2010;88(12):894–7. Landolsi A1, Gahbiche S, Chaafii R, Chabchoub I, Ben Fatma L, Hochlef M, Gharbi O, Ben Ahmed S. Reasons of diagnostic delay of breast cancer in Tunisian women (160 patients in the central region of Tunisia). Tunis Med. 2010;88(12):894–7.
12.
13.
go back to reference Ukwenya AY, Yusufu LM, Nmadu PT, Garba ES, Ahmed A. Delayed treatment of symptomatic breast cancer: the experience from Kaduna, Nigeria. S Afr J Surg. 2008;46(4):106–10.PubMed Ukwenya AY, Yusufu LM, Nmadu PT, Garba ES, Ahmed A. Delayed treatment of symptomatic breast cancer: the experience from Kaduna, Nigeria. S Afr J Surg. 2008;46(4):106–10.PubMed
14.
go back to reference Memon ZA, Shaikh AN, Rizwan S, Sardar MB. Reasons for patient’s delay in diagnosis of breast carcinoma in Pakistan. Asian Pac J Cancer Prev. 2013;14:7409–14.CrossRefPubMed Memon ZA, Shaikh AN, Rizwan S, Sardar MB. Reasons for patient’s delay in diagnosis of breast carcinoma in Pakistan. Asian Pac J Cancer Prev. 2013;14:7409–14.CrossRefPubMed
15.
go back to reference Montazeri A, Ebrahimi M, Mehrdad N, Ansari M, Sajadian A. Delayed presentation in breast cancer: a study in Iranian women. BMC Women’s Health. 2003;3:4.CrossRefPubMedPubMedCentral Montazeri A, Ebrahimi M, Mehrdad N, Ansari M, Sajadian A. Delayed presentation in breast cancer: a study in Iranian women. BMC Women’s Health. 2003;3:4.CrossRefPubMedPubMedCentral
16.
go back to reference Smith EC, Ziogas A, Anton-Culver H. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race. JAMA Surg. 2013;24:1–8. Smith EC, Ziogas A, Anton-Culver H. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race. JAMA Surg. 2013;24:1–8.
17.
go back to reference Hansen RP, Vedsted P, Sokolowski I, et al. General practitioner characteristics and delay in cancer diagnosis. A population-based cohort study. BMC Fam Pract. 2011;12:100.CrossRefPubMedPubMedCentral Hansen RP, Vedsted P, Sokolowski I, et al. General practitioner characteristics and delay in cancer diagnosis. A population-based cohort study. BMC Fam Pract. 2011;12:100.CrossRefPubMedPubMedCentral
18.
go back to reference Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Littlejohns P, Richards MA. Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet. 1999;353(9159):1127–31.CrossRefPubMed Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Littlejohns P, Richards MA. Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet. 1999;353(9159):1127–31.CrossRefPubMed
19.
go back to reference Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353(9159):1119–26.CrossRefPubMed Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353(9159):1119–26.CrossRefPubMed
20.
go back to reference Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G, Brenner H. Socio-demographic factors, health behavior and late stage diagnosis of breast cancer in Germany: a population based study. J Clin Epidemiol. 2001;54:719–27.CrossRefPubMed Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G, Brenner H. Socio-demographic factors, health behavior and late stage diagnosis of breast cancer in Germany: a population based study. J Clin Epidemiol. 2001;54:719–27.CrossRefPubMed
21.
go back to reference Moritz DJ, Satariano WA. Factors predicting stage of breast cancer at diagnosis in middle aged and elderly women: the role of living arrangements. J Clin Epidemiol. 1993;46:443–54.CrossRefPubMed Moritz DJ, Satariano WA. Factors predicting stage of breast cancer at diagnosis in middle aged and elderly women: the role of living arrangements. J Clin Epidemiol. 1993;46:443–54.CrossRefPubMed
22.
go back to reference Sharma K, Costas A, Shulman LN, Meara JG. A systematic review of barriers to breast cancer care in developing countries resulting in delayed patientpresentation. J Oncol. 2012;2012:121873. Sharma K, Costas A, Shulman LN, Meara JG. A systematic review of barriers to breast cancer care in developing countries resulting in delayed patientpresentation. J Oncol. 2012;2012:121873.
23.
go back to reference Facione NC, Miaskowski C, Dodd MJ, Paul SM. The selfreported likelihood of patient delay in breast cancer: new thoughts for early detection. Prev Med. 2002;34:397–407.CrossRefPubMed Facione NC, Miaskowski C, Dodd MJ, Paul SM. The selfreported likelihood of patient delay in breast cancer: new thoughts for early detection. Prev Med. 2002;34:397–407.CrossRefPubMed
24.
go back to reference Montella M, Crispo A, Botti G, De Marco M, De Bellis G, Fabbrocini G, et al. Assessment of delay in obtaining definitive breast cancer treatment in southern Italy. Breast Cancer Res Treat. 2001;66:209–15.CrossRefPubMed Montella M, Crispo A, Botti G, De Marco M, De Bellis G, Fabbrocini G, et al. Assessment of delay in obtaining definitive breast cancer treatment in southern Italy. Breast Cancer Res Treat. 2001;66:209–15.CrossRefPubMed
25.
go back to reference Jassem J, Ozmen V, Bacanu F, Drobniene M, Eglitis J, Lakshmaiah KC, Kahan Z, Mardiak J, Pieńkowski T, Semiglazova T, Stamatovic L,Timcheva C, Vasovic S, Vrbanec D, Zaborek P. Delays in diagnosis and treatment of breast cancer: a multinational analysis. Eur J Public Health. 2013;12:1–7. Jassem J, Ozmen V, Bacanu F, Drobniene M, Eglitis J, Lakshmaiah KC, Kahan Z, Mardiak J, Pieńkowski T, Semiglazova T, Stamatovic L,Timcheva C, Vasovic S, Vrbanec D, Zaborek P. Delays in diagnosis and treatment of breast cancer: a multinational analysis. Eur J Public Health. 2013;12:1–7.
26.
go back to reference Arndt V, Stumer T, Stegmaier C, Ziegler H, Dhom G, Brenner H. Patient delay and stage of diagnosis among breast cancer patients in Germany-a population study. Br J Cancer. 2002;86:1034–40.CrossRefPubMedPubMedCentral Arndt V, Stumer T, Stegmaier C, Ziegler H, Dhom G, Brenner H. Patient delay and stage of diagnosis among breast cancer patients in Germany-a population study. Br J Cancer. 2002;86:1034–40.CrossRefPubMedPubMedCentral
27.
go back to reference Neal RD, Allgar VL. Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the “National Survey of NHS Patients: Cancer”. Br J Cancer. 2005;92:1971e5.CrossRef Neal RD, Allgar VL. Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the “National Survey of NHS Patients: Cancer”. Br J Cancer. 2005;92:1971e5.CrossRef
28.
go back to reference Andersen RS, Vedsted P, Olesen F, Bro F, Sondergaard J. Patient delay in cancer studies: a discussion of methods and measures. BMC Health Serv Res. 2009;9:189.CrossRefPubMedPubMedCentral Andersen RS, Vedsted P, Olesen F, Bro F, Sondergaard J. Patient delay in cancer studies: a discussion of methods and measures. BMC Health Serv Res. 2009;9:189.CrossRefPubMedPubMedCentral
29.
go back to reference Grunfeld EA, Hunter MS, Ramirez AJ, Richards MA. Perceptions of breast cancer across the lifespan. J Psychosom Res. 2003;54(2):141–6.CrossRefPubMed Grunfeld EA, Hunter MS, Ramirez AJ, Richards MA. Perceptions of breast cancer across the lifespan. J Psychosom Res. 2003;54(2):141–6.CrossRefPubMed
30.
go back to reference Goodson 3rd WH, Moore 2nd DH. Causes of physician delay in the diagnosis of breast cancer. Arch Intern Med. 2002;162(12):1343–8.CrossRefPubMed Goodson 3rd WH, Moore 2nd DH. Causes of physician delay in the diagnosis of breast cancer. Arch Intern Med. 2002;162(12):1343–8.CrossRefPubMed
32.
go back to reference Montella M, Crispo A, D'Aiuto G, De Marco M, de Bellis G, Fabbrocini G, Pizzorusso M, Tamburini M, Silvestra P. Determinant factors for diagnostic delay in operable breast cancer patients. Eur J Cancer Prev. 2001;10(1):53–9. Montella M, Crispo A, D'Aiuto G, De Marco M, de Bellis G, Fabbrocini G, Pizzorusso M, Tamburini M, Silvestra P. Determinant factors for diagnostic delay in operable breast cancer patients. Eur J Cancer Prev. 2001;10(1):53–9.
Metadata
Title
Factors influencing diagnosis delay of advanced breast cancer in Moroccan women
Authors
A. Maghous
F. Rais
S. Ahid
N. Benhmidou
K. Bellahamou
H. Loughlimi
E. Marnouche
S. Elmajjaoui
H. Elkacemi
T. Kebdani
N. Benjaafar
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2016
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-016-2394-y

Other articles of this Issue 1/2016

BMC Cancer 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine